Labeler
Gland Pharma Limited NDC Codes
Gland Pharma Limited lists 263 finished drug products in the FDA NDC Directory under NDC labeler code 68083.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Drugs
- Enoxaparin Sodium, Vancomycin Hydrochloride, epinephrine, Octreotide Acetate, Atropine, Brimonidine Tartrate and Timolol maleate Ophthalmic Solution, Phenylephrine Hydrochloride, Cisatracurium besylate, Ketamine Hydrochloride, sugammadex, zoledronic acid, Bortezomib, Epoprostenol, Vasopressin, Latanoprostene Bunod Ophthalmic Solution, 0.024%
- Active ingredients
- Enoxaparin sodium, Vancomycin hydrochloride, Epinephrine, Brimonidine tartrate, Timolol maleate, Octreotide acetate, Atropine sulfate, Phenylephrine hydrochloride, Cisatracurium besylate, Ketamine hydrochloride, Sugammadex sodium, Zoledronic acid
- NDC labeler codes
- 68083
- Strengths (from the 100 most recently listed products)
- Epinephrine 1 mg/mL; Timolol maleate 5 mg/mL; Atropine sulfate 10 mg/mL; Brimonidine tartrate 2 mg/mL; Phenylephrine hydrochloride 25 mg/mL; Latanoprostene bunod .24 mg/mL; Acetaminophen 10 mg/mL; Cisatracurium besylate 2 mg/mL; Chlorpromazine hydrochloride 25 mg/mL; Midazolam hydrochloride 1 mg/mL; Travoprost .04 mg/mL; Fosphenytoin sodium 50 mg/mL; Desmopressin acetate 4 ug/mL; Cyanocobalamin 1000 ug/mL; Sugammadex sodium 200 mg/2mL; Sugammadex sodium 500 mg/5mL; Brimonidine tartrate 1 mg/mL; Zoledronic acid .04 mg/mL; Bortezomib 2.5 mg/1; Bortezomib 1 mg/1
- Dosage forms
- Injection, Solution, Injection, Solution/ drops, Injection, Powder, Lyophilized, For solution, Injection, Solution, Concentrate, Solution, Injection, Emulsion, Kit, Solution, Gel forming / drops
- Routes
- Intravenous, Subcutaneous, Intramuscular, Ophthalmic, Intraocular, Intra-articular, Intralesional, Soft tissue
- Drug classes (FDA established)
- alpha-Adrenergic Agonist, beta-Adrenergic Agonist, Low Molecular Weight Heparin, Glycopeptide Antibacterial, Catecholamine, beta-Adrenergic Blocker, Somatostatin Analog, Anticholinergic, Cholinergic Muscarinic Antagonist, Histamine-1 Receptor Antagonist, alpha-1 Adrenergic Agonist, Nondepolarizing Neuromuscular Blocker, Phenothiazine, Prostaglandin Analog, General Anesthetic, Bisphosphonate, Proteasome Inhibitor, Prostacycline Vasodilator, Benzodiazepine, Antiarrhythmic, Anti-epileptic Agent, Factor VIII Activator, Vasopressin Analog, Vitamin B12, Histamine-1 Receptor Inhibitor, Mast Cell Stabilizer, Folate Analog, P2Y12 Platelet Inhibitor, Carbonic Anhydrase Inhibitor, Vasoconstrictor, Norepinephrine Releasing Agent, Central alpha-2 Adrenergic Agonist, Vitamin K, Warfarin Reversal Agent, Macrolide Antimicrobial, Macrolide, Thiazide Diuretic, Hematopoietic Stem Cell Mobilizer, Antifibrinolytic Agent, Microtubule Inhibitor, Nucleoside Metabolic Inhibitor, Azole Antifungal, Corticosteroid, Copper Absorption Inhibitor, Ergotamine Derivative, Anti-coagulant, Direct Thrombin Inhibitor, Antidote, Tetracycline-class Drug, Gonadotropin Releasing Hormone Receptor Antagonist, Alkylating Drug
- HCPCS / J-code
- J0171 — Injection, adrenalin, epinephrine, 0.1 mg, J0131 — Injection, acetaminophen, 10 mg
- Package NDCs
- 105 (from the 100 most recently listed products)
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|
| Fluorouracil | Fluorouracil 50 mg/mL | Injection, SolutionIntravenous | 68083-292 | 68083-0292-01 | — |
| Mesnamesna injection | Mesna 100 mg/mL | SolutionIntravenous | 68083-161 | 68083-0161-0168083-0161-10 | — |
| Levetiracetam | Levetiracetam 5 mg/mL | InjectionIntravenous | 68083-152 | 68083-0152-10 | — |
| Levetiracetam | Levetiracetam 10 mg/mL | InjectionIntravenous | 68083-153 | 68083-0153-10 | — |
| Levetiracetam | Levetiracetam 15 mg/mL | InjectionIntravenous | 68083-154 | 68083-0154-10 | — |
| Fluorouracil | Fluorouracil 50 mg/mL | Injection, SolutionIntravenous | 68083-269 | 68083-0269-10 | — |
| Fluorouracil | Fluorouracil 50 mg/mL | Injection, SolutionIntravenous | 68083-270 | 68083-0270-10 | — |
| Oxaliplatin | Oxaliplatin 5 mg/mL | Injection, SolutionIntravenous | 68083-176 | 68083-0176-01 | — |
| Oxaliplatin | Oxaliplatin 5 mg/mL | Injection, SolutionIntravenous | 68083-177 | 68083-0177-01 | — |
| Oxaliplatin | Oxaliplatin 5 mg/mL | Injection, SolutionIntravenous | 68083-314 | 68083-0314-01 | — |
| Caspofungin Acetate | Caspofungin acetate 7 mg/mL | Injection, Powder, Lyophilized, For solutionIntravenous | 68083-159 | 68083-0159-01 | — |
| Caspofungin Acetate | Caspofungin acetate 5 mg/mL | Injection, Powder, Lyophilized, For solutionIntravenous | 68083-158 | 68083-0158-01 | — |
| Deferoxamine mesylate | Deferoxamine mesylate 500 mg/1 | Injection, Powder, Lyophilized, For solutionIntramuscular, Intravenous, Subcutaneous | 68083-172 | 68083-0172-01 | — |
| Deferoxamine mesylate | Deferoxamine mesylate 2 g/1 | Injection, Powder, Lyophilized, For solutionIntramuscular, Intravenous, Subcutaneous | 68083-173 | 68083-0173-01 | — |
| Doxorubicin Hydrochloride | Doxorubicin hydrochloride 2 mg/mL | Injection, SolutionIntravenous | 68083-248 | 68083-0248-01 | — |
| Doxorubicin Hydrochloride | Doxorubicin hydrochloride 2 mg/mL | Injection, SolutionIntravenous | 68083-249 | 68083-0249-01 | — |
| Doxorubicin Hydrochloride | Doxorubicin hydrochloride 2 mg/mL | Injection, SolutionIntravenous | 68083-250 | 68083-0250-01 | — |
| Oxaliplatin | Oxaliplatin 50 mg/10mL | Injection, Powder, Lyophilized, For solutionIntravenous | 68083-170 | 68083-0170-01 | — |
| Oxaliplatin | Oxaliplatin 100 mg/20mL | Injection, Powder, Lyophilized, For solutionIntravenous | 68083-171 | 68083-0171-01 | — |
| Argatroban | Argatroban 125 mg/125mL | SolutionIntravenous | 68083-141 | 68083-0141-02 | — |
| Etomidateetomidate injection | Etomidate 2 mg/mL | SolutionIntravenous | 68083-234 | 68083-0234-10 | — |
| Etomidateetomidate injection | Etomidate 2 mg/mL | SolutionIntravenous | 68083-235 | 68083-0235-10 | — |
| Meropenem | Meropenem 500 mg/20mL | InjectionIntravenous | 68083-146 | 68083-0146-10 | — |
| Meropenem | Meropenem 1 g/30mL | InjectionIntravenous | 68083-147 | 68083-0147-10 | — |
| Cisplatin | Cisplatin 1 mg/mL | Injection, SolutionIntravenous | 68083-162 | 68083-0162-01 | — |
| Cisplatin | Cisplatin 1 mg/mL | Injection, SolutionIntravenous | 68083-163 | 68083-0163-01 | — |
| Zoledronic acid | Zoledronic acid 5 mg/100mL | InjectionIntravenous | 68083-256 | 68083-0256-01 | — |
| Heparin Sodium | Heparin sodium 5000 [USP'U]/mL | InjectionIntravenous, Subcutaneous | 68083-136 | 68083-0136-25 | — |
| Tranexamic acid | Tranexamic acid 100 mg/mL | Injection, SolutionIntravenous | 68083-160 | 68083-0160-10 | — |
| Carboplatin | Carboplatin 10 mg/mL | Injection, SolutionIntravenous | 68083-192 | 68083-0192-01 | — |
| Carboplatin | Carboplatin 10 mg/mL | Injection, SolutionIntravenous | 68083-190 | 68083-0190-01 | — |
| Carboplatin | Carboplatin 10 mg/mL | Injection, SolutionIntravenous | 68083-191 | 68083-0191-01 | — |
| Carboplatin | Carboplatin 10 mg/mL | Injection, SolutionIntravenous | 68083-193 | 68083-0193-01 | — |
| Olopatadine Hydrochloride Ophthalmic Solutionolopatadine hydrochloride ophthalmic | Olopatadine hydrochloride 1 mg/mL | Solution/ dropsOphthalmic | 68083-477 | 68083-0477-01 | — |
| Haloperidol Decanoate | Haloperidol decanoate 50 mg/mL | InjectionIntramuscular | 68083-137 | 68083-0137-0268083-0137-10 | — |
| Haloperidol Decanoate | Haloperidol decanoate 100 mg/mL | InjectionIntramuscular | 68083-138 | 68083-0138-0268083-0138-10 | — |
| Adenosine | Adenosine 3 mg/mL | SolutionIntravenous | 68083-156 | 68083-0156-10 | — |
| Adenosine | Adenosine 3 mg/mL | SolutionIntravenous | 68083-157 | 68083-0157-10 | — |
| Dexrazoxanedexrazoxane for injection | Dexrazoxane hydrochloride 500 mg/50mL | Injection, Powder, Lyophilized, For solutionIntravenous | 68083-195 | 68083-0195-01 | — |
| ketorolac tromethamine | Ketorolac tromethamine 15 mg/mL | Injection, SolutionIntramuscular, Intravenous | 68083-132 | 68083-0132-10 | — |
| ketorolac tromethamine | Ketorolac tromethamine 30 mg/mL | Injection, SolutionIntramuscular, Intravenous | 68083-133 | 68083-0133-10 | — |
| ketorolac tromethamine | Ketorolac tromethamine 30 mg/mL | Injection, SolutionIntramuscular | 68083-134 | 68083-0134-10 | — |
| Paclitaxel Paclitaxelpaclitaxel | Paclitaxel 6 mg/mL | Injection, SolutionIntravenous | 68083-179 | 68083-0179-01 | — |
| Paclitaxel Paclitaxelpaclitaxel | Paclitaxel 6 mg/mL | Injection, SolutionIntravenous | 68083-178 | 68083-0178-01 | — |
| Paclitaxel Paclitaxelpaclitaxel | Paclitaxel 6 mg/mL | Injection, SolutionIntravenous | 68083-180 | 68083-0180-01 | — |
| Zoledronic Acid | Zoledronic acid 5 mg/100mL | Injection, SolutionIntravenous | 68083-135 | 68083-0135-01 | — |
| Vecuronium Bromide | Vecuronium bromide 1 mg/mL | Injection, Powder, Lyophilized, For solutionIntravenous | 68083-139 | 68083-0139-10 | — |
| Vecuronium Bromide | Vecuronium bromide 1 mg/mL | Injection, Powder, Lyophilized, For solutionIntravenous | 68083-140 | 68083-0140-10 | — |
| Polymyxin Bpolymyxin b sulfate | Polymyxin b sulfate 500000 [USP'U]/1 | Injection, Powder, Lyophilized, For solutionIntramuscular, Intrathecal, Intravenous, Ophthalmic | 68083-174 | 68083-0174-10 | — |
| Vancomycin Hydrochloride | Vancomycin hydrochloride 500 mg/10mL | Injection, Powder, Lyophilized, For solutionIntravenous | 68083-143 | 68083-0143-25 | — |
Gland Pharma Limited: common questions
- What is Gland Pharma Limited's NDC labeler code?
- 68083. The labeler code is the first segment of each NDC. About labeler codes.
- Is there a J-code for Gland Pharma Limited?
- Med-Code's HCPCS directory matches J0171, J0131 to these products. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.